LQDA
LIQUIDIA CORP
Health Care·Pharmaceuticals·UNITED STATES
$71.05
MCap $6.4B
as of 2026-08-20
Total
B8w
Fund
C8w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.24
Sentiment 73.0%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$71.05
Adaptive Mean
$72.08
-1.03 vs mean
Adaptive σ
2.16
MIDOS BB
$67.76 – $76.40
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+1.01
ROE
131.8%
Z +0.72
Rev Gr
1842.7%
Z +4.91
EPS Gr
—
Z +0.12
OPM Gr
1181.7%
Z +0.36
FCF Yld
1.2%
Z +0.11
EPS Surp
-0.1%
Z +0.14
EPS 3mo Δ
270.6%
Z +0.71
Fwd P/E
12.39
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
5.95
Q6M
12.13
Q12M
9.11
MA 30/100
1.291
Bullish (MA30 > MA100)
α (Jensen)
0.6802
β (12M)
0.90
σ (12M)
0.654
Divergence — Fundamentals vs Momentum
Z Percentile
98%
Q Percentile
95%
Divergence
+3.2
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
73.8
RS Pctl
96%
RS Decile
D10
Persistence
8w
at grade B
Options / OI Analysis
as of 2026-08-10
OI Center
$72.54
-20.0% from spot
Max Pain
$80.00
PCR (OI)
1.34
neutral
Skew
-0.66
OI Composite
-1
neutral
Direction
strong_bearish